Efficacy of suicide gene therapy in hypoxic rat 9L glioma cells.
Viral vector mediated suicide gene therapy (SGT) involving thymidine kinase (TK) or cytosine deaminase (CD) have considerable promise in the treatment of malignant brain tumors. An unresolved issue is to what extent tumor hypoxia influences the outcome of SGT since brain tumors characterized by regions of hypoxia have potentially reduced cellular metabolism and SGT's cytotoxicity is manifest through cellular metabolism. We studied in vitro and in vivo, the effect of hypoxia on the cytotoxicity of SGT in rat 9L glioma cells. Neither acute nor chronic hypoxia affected the cell killing of SGT by TK or CD. In vivo confirmation that SGT efficacy was not adversely affected by tumor hypoxia using the hypoxic cell marker pimonidazole was shown by the absence of a change in tumor hypoxia by SGT. These studies support the use of SGT utilizing either TK or CD gene strategies even when tumors are characterized by a hypoxic microenvironment.
Kumar
S
S
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA. skumar4@hfhs.org
Brown
S L
SL
Kolozsvary
A
A
Freytag
S O
SO
Kim
J H
JH
D000818:Animals; D001932:Brain Neoplasms / Q000628:therapy*; D015687:Cell Hypoxia / Q000502:physiology*; D045744:Cell Line, Tumor; D043525:Cytosine Deaminase / Q000235:genetics; D041722:Genes, Transgenic, Suicide; D015316:Genetic Therapy; D005910:Glioma / Q000628:therapy*; D008297:Male; D051379:Mice; D051381:Rats; D013937:Thymidine Kinase / Q000235:genetics
D013937:Thymidine Kinase; D043525:Cytosine Deaminase